| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.09 | 0.06 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.07 | 0.06 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.06 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.06 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.07 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |